PUMA BIOTECHNOLOGY, INC.

PBYI · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.4B · 179 employees
279
SEC Filings
$9.55
Close 2026-09-04
179
Employees

Business Summary

Puma Biotechnology, Inc. is a biopharmaceutical company that develops and commercializes innovative cancer therapies. Its primary commercial product is NERLYNX (neratinib), an oral irreversible tyrosine kinase inhibitor approved in the U.S. for early stage and metastatic HER2-positive breast cancer. The company also in-licensed alisertib from Takeda, a selective Aurora Kinase A inhibitor under development for small cell lung cancer and hormone receptor-positive breast cancer.

Latest Stock Quote

PBYI 2026-09-04 $9.55 O:$9.4 H:$9.6374 L:$9.305 Vol:0.2M VWAP:$9.4997
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001437749-26-005891EDGAR108K words
2025-02-272024-12-310001437749-25-005496EDGAR105K words
2024-02-292023-12-310001437749-24-006121EDGAR103K words
2023-03-022022-12-310001437749-23-005233EDGAR—
2022-03-032021-12-310001437749-22-005164EDGAR—
2021-03-012020-12-310001564590-21-009840EDGAR—
2020-02-282019-12-310001564590-20-007591EDGAR—
2019-03-012018-12-310001564590-19-005830EDGAR—
2018-03-092017-12-310001564590-18-005152EDGAR—
2017-03-012016-12-310001564590-17-003090EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001437749-26-026311EDGAR35K words
2025-11-062025-09-300001437749-25-033633EDGAR36K words
2025-08-072025-06-300001437749-25-025470EDGAR36K words
2025-05-082025-03-310001437749-25-015533EDGAR32K words
2024-11-072024-09-300001437749-24-033955EDGAR34K words
2024-08-012024-06-300001437749-24-024309EDGAR34K words
2024-05-022024-03-310001437749-24-014395EDGAR30K words
2023-11-022023-09-300001437749-23-030028EDGAR39K words
2023-08-032023-06-300001437749-23-021972EDGAR39K words
2023-05-042023-03-310001437749-23-012589EDGAR—
2022-11-032022-09-300001437749-22-025787EDGAR—
2022-08-042022-06-300001437749-22-018920EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001437749-26-026282EDGAR4K words
2026-02-260001437749-26-005869EDGAR4K words
2025-11-060001437749-25-033604EDGAR4K words
2025-08-070001437749-25-025463EDGAR4K words
2025-06-240001437749-25-021153EDGAR16K words
2025-06-130001437749-25-020321EDGAR1K words
2025-05-090001437749-25-015648EDGAR1K words
2025-05-080001437749-25-015514EDGAR3K words
2025-02-270001437749-25-005477EDGAR5K words
2024-11-070001437749-24-033929EDGAR4K words

279 total filings indexed. 247 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

her2-positive-breast-cancer early-stage-breast-cancer metastatic-breast-cancer small-cell-lung-cancer hormone-receptor-positive-breast-cancer triple-negative-breast-cancer oncology

Company Identity

CIK0001401667
TickerPBYI
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.pumabiotechnology.com
Listed2012-03-21

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: e13eb4af22820e4674bcb4339250d4a5c5908c26738a3ef65c1de33fb5623ee2
parent: 2453a0fccd04d939633688afd65892efd871d76d8073d26e2e6ff2584aa22fbd
content hash: f88d2a7e76f4ac91bcbbc2015e07461069dc178563f8b4ce24fe744da15c7ddb
signed: 2026-09-28T19:02:35.091Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up PBYI using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on PBYI, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/PBYI (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.